By Our Reporter
NEWYORK|SHIFTMEDIA| The wait for the Coronavirus vaccine is expected to be longer after one of the firms,
Pfizer revealed that it expects to ship just half the number of coronavirus vaccines it had originally promised in 2020.
The setback raises questions about how fast vaccinations for the deadly virus that has wreaked havoc across the world will be able to be rolled out to the billions of people who need it worldwide.
“Scaling up the raw material supply chain took longer than expected,” a company spokeswoman said.
“It’s important to highlight that the outcome of the clinical trial was somewhat later than the initial projection.”
The company blamed supply chain delays tied to the fact that it had found raw materials in early production that did not meet its standards for the shortfall.
Pfizer and partner BioNTech SE had hoped to roll out 100 million vaccines worldwide by the end of 2020. On Thursday, that was cut to 50 million.
Australia has signed a deal for 10 million of the Pfizer vaccines, and it’s not known how the supply shortfall will affect that deal.